Unique Ingredient Identifier B697894SGQ is listed as a ingredient substance
| RN | 25322-68-3 |
| EC | 225-856-4 |
| NCIT | C84080 |
| RXCUI | 8514 |
| MF | Polymer substance not supported |
UNII B697894SGQ POLYETHYLENE GLYCOL 400 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IM - IV | INJECTION | 20.3 % |
| IM - IV | SOLUTION, INJECTION | 18 % |
| INTRAVENOUS | INJECTABLE | 0.67 ML/ML |
| INTRAVENOUS | INJECTION | 11.25 % |
| INTRAVENOUS | SOLUTION, INJECTION | 75.58 % |
| INTRAVENOUS INFUSION | INJECTION | 68.51 % |
| INTRAVENOUS INFUSION | INJECTION | 7.47 g/1VIAL |
| INTRAVENOUS INFUSION | INJECTION | 0.67 mL/1mL |
| INTRAVENOUS INFUSION | SOLUTION, INJECTION | 0.67 MG/ML |
| IV(INFUSION) | INJECTION | 11.25 % |
| IV(INFUSION) | INJECTION | 0.67 ML/1ML |
| NASAL | SPRAY, METERED | 20 % |
| OPHTHALMIC | OINTMENT | 5 % |
| ORAL | AEROSOL | NA |
| ORAL | CAPSULE | 960 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN | 950 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL | 50 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 103.55 MG |
| ORAL | CAPSULE, DELAYED ACTION | 2.74 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 2.74 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 1.7 MG |
| ORAL | CAPSULE, SOFT GELATIN | 1057 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 324.5 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 11.32 MG |
| ORAL | CONCENTRATE | 600 MG/1ML |
| ORAL | FILM, SOLUBLE | 4.76 MG |
| ORAL | SOLUTION | 8549 MG/20ML |
| ORAL | SOLUTION | 563.5 mg/5 mL |
| ORAL | SOLUTION, CONCENTRATE | 60 % |
| ORAL | SUSPENSION | 250 MG/5ML |
| ORAL | SYRUP | 74 MG/1ML |
| ORAL | TABLET | 105.07 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 20 MG |
| ORAL | TABLET, COATED | 3.15 MG |
| ORAL | TABLET, DELAYED ACTION | 4.57 MG |
| ORAL | TABLET, DELAYED RELEASE | 2 MG |
| ORAL | TABLET, ENTERIC COATED PARTICLES | 12.5 MG |
| ORAL | TABLET, EXTENDED RELEASE | 45 MG |
| ORAL | TABLET, FILM COATED | 5.91 MG |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 1.13 MG |
| ORAL | TABLET, SUSTAINED ACTION | 45 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 1.8 MG |
| ORAL | TABLET, SUSTAINED RELEASE, FILM COATED | 1.28 MG |
| RECTAL | SUPPOSITORY | NA |
| TOPICAL | CREAM | 1.5 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 7.5 %W/W |
| TOPICAL | DRESSING | NA |
| TOPICAL | EMULSION, CREAM | 7.5 %W/W |
| TOPICAL | GEL | 45 %W/W |
| TOPICAL | LOTION | 5 %W/W |
| TOPICAL | OINTMENT | 65 %W/W |
| TOPICAL | SOLUTION | 69.9 %W/W |
| TOPICAL | SPONGE | NA |
| TOPICAL | SWAB | NA |
| VAGINAL | SUPPOSITORY | NA |